Skip to main content

Predicting Dental Implant Failure When Failures Cluster in Patients: A Critical Appraisal of Existing Models and a TRIPOD+AI Protocol for a Shared-Frailty Model With Dynamic Updating

Paper type
Prediction-model development and external-validation protocol with critical methodological review
Status
Original Work · Working Paper
Keywords:
dental implant failure · risk prediction · shared frailty · clustered survival data · calibration · TRIPOD+AI · machine learning · external validation
Contents
  1. 1Introduction and Clinical Significance
  2. 2Critical Review of the Established Literature
  3. 3Identification of the Specific Research Gap
  4. 4Scientific Objective and Hypothesis
  5. 5Theoretical Foundation: Shared Frailty and Dynamic Prediction
  6. 6Methodology
  7. 7Explicitly Labeled Theoretical Predictions
  8. 8Discussion: Mechanisms and Competing Explanations
  9. 9Implications for Implant Surgery and Restorative Dentistry
  10. 10Technical and Clinical Limitations
  11. 11Proposed Validation Pathway
  12. 12Future Research Directions
  13. 13Evidence-Calibrated Conclusion

Abstract

Background: Implant failure is uncommon, multifactorial, and unevenly distributed: in large cohorts a small proportion of patients account for the majority of failed implants. Published prediction models, including recent machine-learning models, have generally analyzed implants as independent observations, relied on retrospective single-center data, and reported discrimination without calibration or external validation.

Objective: To appraise how implant-failure risk has been modeled, to identify the statistical consequences of ignoring within-patient clustering, and to specify a model and validation study that address them.

Methods: Critical review of cohort studies, meta-analyses of individual risk factors, and systematic appraisals of prediction models. A gamma shared-frailty proportional-hazards model was formulated, and the posterior expectation of a patient's frailty given observed failures was derived for use in dynamic prediction. A development and validation protocol was written against TRIPOD+AI and PROBAST+AI, with sample size determined by current criteria for time-to-event prediction models.

Findings: Smoking, low insertion torque with early loading, short implants, poor bone quality, certain medications, and bruxism recur as risk indicators, but most estimates derive from a small number of centers and are confounded. Appraisals of existing prediction models find high risk of bias and little external validation. We hypothesize that a shared-frailty model yields an external calibration slope closer to one and a Brier score at least 10 percent lower than an otherwise identical implant-level model, and that incorporating a patient's prior failure improves prediction for subsequent implants. A frailty variance indistinguishable from zero, or no calibration difference, would refute the hypothesis.

Conclusions: The clustering of failures is the most reproducible quantitative fact about implant failure and the least exploited in prediction. Whether exploiting it improves predictions that matter clinically is testable with existing registries. No model has been fitted for this manuscript, and no performance figures are reported.

Keywords: dental implant failure; risk prediction; shared frailty; clustered survival data; calibration; TRIPOD+AI; machine learning; external validation

1. Introduction and Clinical Significance

A patient considering implant treatment wants a number: the chance that this implant, in this mouth, will fail. Clinicians answer with population survival figures. A systematic review with sensitivity analysis estimated ten-year implant survival in the mid-90 percent range, somewhat lower once losses to follow-up were imputed [1], and a review of longitudinal studies with at least ten years of follow-up reported similar cumulative figures [2]. In a Swedish population sample, however, early implant loss occurred in 4.4 percent of patients and late loss in a further 4.2 percent over nine years, and a meaningful share of patients lost at least one implant [3]. Average survival is high; the experience of the individual who loses implants is not captured by the average.

Decades of observation have produced a long list of factors associated with failure and no agreed way of combining them. A comprehensive review of reasons for implant failure enumerated patient, site, implant, and procedural factors and stressed how often the supporting studies were retrospective, univariable, or confounded [4]. Earlier reviews of the biological factors contributing to failure made the same point and proposed that host-related susceptibility, as distinct from local conditions, explains why failures concentrate in certain individuals [5, 6]. That concentration is the starting point of this paper.

Prediction matters for three practical decisions: whether to offer implants at all to a patient at elevated risk, how to modify the protocol (staged surgery, delayed loading, more implants for redundancy), and what to do after a first failure. The last is the commonest dilemma and the one for which population figures are least useful. A model that could revise a patient's risk in light of what has already happened in that patient would address it directly.

2. Critical Review of the Established Literature

Risk factors

Meta-analyses of individual exposures give the best-quantified associations. Smoking was associated with a significantly higher risk of implant failure, postoperative infection, and marginal bone loss in a meta-analysis of comparative studies [7]. Diabetes, in contrast, was not associated with a significant difference in failure in the same group's systematic review, though marginal bone loss was greater [8]. Pharmacoepidemiologic cohort studies have reported associations between implant failure and the use of selective serotonin reuptake inhibitors [9] and proton pump inhibitors [10, 11]; these are observational findings in which the underlying conditions and correlated behaviors are plausible confounders.

Large single-center series supply multivariable estimates. In a retrospective analysis of more than ten thousand implants, smoking and antidepressant intake were among the factors associated with early failure [12]. Bruxism was associated with failure in a multilevel survival analysis from the same institution [13]. A multifactorial analysis of several thousand implant operations at a referral clinic related early failure to clinical factors including jaw, bone conditions, and surgical variables [14]. Earlier reports from university and private practice settings identified age, smoking, diabetes, head and neck irradiation, and implant site as associated factors [15] and provided multivariable survival analyses of several thousand implants [16]. Operator effects exist: failure rates differed between surgeons in one large dataset [17], and a meta-analysis found that experience defined by the number of implants a surgeon had placed, though not experience defined by specialty, was associated with implant failure [18]. Long-run institutional data show that the incidence of first implant failure has varied with surgical era and implant surface [19].

Much of the contemporary multivariable evidence originates from one Swedish specialist clinic. The consistency of its findings is partly the consistency of a single population, a single referral pattern, and a single group of analysts.

Clustering

That failures are not independent within patients was demonstrated in the early 1990s, when an analysis of a large hospital system's implants found within-patient clustering of failures and showed that survival estimates which ignored it were misleading [20]. Subsequent methodological work quantified the dependence among implants in the same patient and showed how the choice of statistical unit alters reported results [21], proposed adjusted Kaplan-Meier estimation for clustered implant data [22], and introduced frailty models to dental research for exactly this purpose [23]. An analysis of patient and implant characteristics as prognostic factors found that combinations of unfavorable factors in the same patient, more than any single factor, marked those at risk [24].

The most direct quantification comes from a cluster-behavior analysis of more than eight thousand implants, in which fewer than 5 percent of patients with three or more implants, those who lost at least three, accounted for more than half of all failures, and in which bruxism and antidepressant intake were among the factors associated with cluster behavior [25]. The clinical implication, that a failure is information about the patient, has been stated often. It has rarely been built into a predictive tool.

Existing prediction models

A recent systematic review and critical appraisal of prediction models for implant complications and survival concluded that available models have limited methodological quality and limited external validity [26]. This mirrors the experience in medicine generally, where prediction-model studies are frequently at high risk of bias by the criteria of the PROBAST tool: small numbers of events, data-driven predictor selection, inappropriate handling of missing data, and absent or inadequate validation [27].

Machine-learning approaches have entered the field. Deep-learning models have been trained on radiographs to predict implant loss [28] and osseointegration [29], and unsupervised methods have been used to look for implant "phenotypes" in bone-level data [30]. Systematic reviews of artificial intelligence in implant dentistry describe an expanding literature in which implant-type recognition predominates and outcome prediction rests on small retrospective datasets [31]. Commentators on artificial intelligence in dentistry have warned that such models are often insufficiently validated and that generalizability, not accuracy on held-out data from the same source, is the relevant test [32]. In clinical prediction more broadly, a systematic review found no performance benefit of machine learning over logistic regression when comparisons were at low risk of bias [33].

What is being predicted

Prediction presupposes an agreed outcome, and implant dentistry has several. The criteria proposed in 1986 defined success by immobility, absence of peri-implant radiolucency, limited annual bone loss after the first year, and absence of persistent symptoms [34]; a later consensus graded implants on a scale from success through compromised survival to failure [35]. Most registries record only whether the implant is still present. Survival so defined is objective and consistently ascertainable, which is why it is used here, but it is a low bar, and a model that predicts survival well may say little about the implants that remain in place with advanced bone loss or recurrent technical complications. The distinction matters for interpretation: risk factors for loss of the fixture and risk factors for an unsatisfactory but surviving implant overlap only partly, and the patient's interest lies in the second as much as the first. A prediction model should state which of these it addresses and should not be read as addressing the other.

Methodological standards

Standards now exist against which any new model should be judged. TRIPOD+AI updates reporting guidance for prediction models developed with regression or machine-learning methods [36], and PROBAST+AI updates the assessment of quality, risk of bias, and applicability [37]. Sample-size criteria for model development are based on limiting overfitting and estimating overall risk precisely, and replace the older events-per-variable rule of thumb [38, 39]. Calibration, the agreement between predicted and observed risk, has been called the Achilles heel of predictive analytics because it is commonly neglected and is the property that determines whether predictions can be used for decisions [40]. Performance should be reported with measures of discrimination, calibration, and clinical utility [41], the last by decision-curve analysis [42]. For clustered data specifically, simulation and applied studies show that the effective sample size is reduced by clustering [43], that random-intercept models can improve calibration within clusters [44], and that multilevel survival methods are available and well described [45]. External validation results must be interpreted in light of how similar the validation population is to the development population [46].

3. Identification of the Specific Research Gap

The literature has established a set of recurring risk indicators and the fact of clustering. It has not established a prediction model that is externally validated, calibrated, and reported to current standards, and it has not established whether modeling patient-level susceptibility improves prediction for new patients or for subsequent implants in the same patient.

Existing methods are inadequate in identifiable ways. Analyses at the implant level treat ten implants in one mouth as ten independent pieces of information, which overstates the effective sample size, narrows confidence intervals falsely, and allows patients with many implants to dominate coefficient estimates. Outcome definitions merge early failure, which is a failure to integrate, with late failure, which is loss of established integration, although their causes differ [6]. Predictors such as bone quality and bruxism are recorded subjectively and inconsistently. Many datasets come from specialist referral centers whose case mix and failure rates differ from general practice. Machine-learning studies commonly split implants at random into training and test sets, so that implants from the same patient appear on both sides, a form of leakage that inflates apparent performance whenever outcomes cluster.

The specific gap is the absence of a model that treats the patient as the unit of susceptibility, that is validated in data from different centers, and that makes use of the clinically obvious fact that a patient who has lost an implant is at higher risk of losing another.

4. Scientific Objective and Hypothesis

The objective is to develop and externally validate a time-to-event prediction model for implant failure that represents between-patient heterogeneity by a shared frailty term and that can be updated for an individual patient as outcomes accrue.

Hypothesis H4: in external validation, a gamma shared-frailty model has a calibration slope closer to 1 and a Brier score at least 10 percent lower than a model with the same predictors that treats implants as independent, and dynamic updating of the frailty after a patient's first failure further improves calibration for that patient's later implants.

H4 is falsified if the estimated frailty variance has a 95% confidence interval that includes zero, or if the difference in calibration slope between the two models has a confidence interval that includes zero and the relative difference in Brier score is below 10 percent. The dynamic-updating component is falsified separately if predictions for second and subsequent implants are no better calibrated with the posterior frailty than with the prior. The 10 percent figure is a prespecified judgment of the smallest improvement worth the added complexity.

We do not hypothesize that the frailty model discriminates better between patients at baseline. For a new patient with no implant history the frailty is unknown and predictions rest on measured covariates; any baseline advantage must come from less biased coefficients. The principal expected gain is in calibration and in dynamic prediction.

5. Theoretical Foundation: Shared Frailty and Dynamic Prediction

Model

Index patients by i and implants within patients by j. The hazard of failure for implant j in patient i at time t since placement is

h_(ij)(t) = z_i h_0(t) exp(β^T x_(ij)) (1)

where h0(t) is the baseline hazard, xij is the vector of patient-level and implant-level predictors, β is the vector of log hazard ratios, and zi is an unobserved patient-specific multiplier, the frailty, assumed to follow a gamma distribution with mean 1 and variance θ. When θ equals zero, all patients share the same baseline hazard and the model reduces to the ordinary proportional-hazards model. Larger θ means greater heterogeneity in susceptibility that the measured covariates do not explain. For the gamma frailty, the within-patient association can be summarized by Kendall's coefficient

τ = θ/(θ + 2) (2)

which ranges from 0 (independence) toward 1.

Consequence for information content

If a patient contributes m implants whose outcomes have intraclass correlation ICC, the variance of an estimated mean is inflated by the design effect

DE = 1 + (m - 1) · ICC (3)

so that n implants carry the information of approximately n/DE independent implants. A dataset of ten thousand implants in two thousand five hundred patients is not a dataset of ten thousand independent observations, and the sample-size reasoning in Section 6.6 is conducted accordingly.

Updating risk after an observed outcome

The gamma frailty has a property that makes it clinically useful. Let di be the number of failures observed so far in patient i, and let Λi be that patient's accumulated cumulative hazard, the sum over the patient's implants of the model-predicted cumulative hazard up to the present. The posterior distribution of the frailty is again gamma, with expectation

E(z_i | d_i, Λ_i) = (1/θ + d_i)/(1/θ + Λ_i) (4)

A patient with no failures after long exposure has an expected frailty below 1; a patient with a failure after short exposure has an expected frailty well above 1. The predicted hazard for that patient's next implant is the covariate-based hazard multiplied by this quantity. Equation 4 formalizes the clinical intuition about the patient who has already lost an implant and makes it quantitative, conditional on θ. The updating is strongest when θ is large and exposure small, and vanishes as θ approaches zero.

Early and late failure

Early failure reflects the events of healing; late failure reflects the events of function. Their predictors need not coincide, and their hazards have different shapes, the first concentrated in the first months, the second low and roughly constant or slowly rising. The model accommodates this with a flexible baseline hazard and with time-varying coefficients for predictors whose effect is expected to differ by phase, such as insertion torque (early) and bruxism or periodontitis history (late). Whether a single frailty governs both phases is an empirical question; a patient susceptible to non-integration is not necessarily susceptible to late loss. The protocol tests a model with correlated phase-specific frailties against the single-frailty model.

Measures of performance

Calibration slope is the coefficient obtained by regressing the observed outcome on the model's linear predictor in validation data; a slope of 1 indicates neither over- nor under-fitting. The Brier score at time horizon t is the mean squared difference between predicted probability and observed status, with appropriate weighting for censoring. Clinical utility is expressed as net benefit at a threshold probability pt:

NB = TP/n - FP/n · p_t/(1 - p_t) (5)

where TP and FP are the numbers of true- and false-positive classifications among n individuals when those with predicted risk above pt are classified as high risk [42]. For implant decisions a plausible threshold range must be elicited from clinicians and patients, since the action at stake, declining or modifying treatment, has its own costs.

6. Methodology

Design, reporting, and registration

The study is a retrospective-cohort model development with temporal and geographic external validation, reported according to TRIPOD+AI [36]; risk of bias is addressed prospectively against the PROBAST+AI domains [37]. The protocol and analysis code are to be registered and deposited before data access.

Data sources

Development data are drawn from at least two institutional implant registries with consecutive enrollment, patient identifiers linking all implants in the same person, placement dates, and failure dates. External validation uses registries from different institutions and, if obtainable, a practice-based network, since performance in general practice is the stated use case. Datasets from a single clinic, however large, are insufficient for the purpose. Consecutive enrollment is required to avoid the selection inherent in convenience samples.

Outcome

The outcome is implant failure, defined as removal or loss of the implant for any reason, with time measured from placement. Early failure (before or at abutment connection, or within six months of placement where no second stage occurs) and late failure are flagged. Implants still in place at last follow-up are censored. Death and loss to follow-up are recorded separately; death is treated as a competing event in a sensitivity analysis.

Candidate predictors

Predictors are prespecified from the literature reviewed in Section 2.1 and restricted to information available at the time of treatment planning or, for a second model, at the end of surgery (Table 1). No data-driven selection from a larger pool is performed. Continuous predictors are modeled with restricted cubic splines. Missing predictor values are handled by multiple imputation that includes the outcome and respects the clustered structure.

Table 1. Prespecified candidate predictors, with the level at which each varies.
DomainPredictorsLevel
Demographic and behavioralAge; sex; smoking status and intensityPatient
MedicalDiabetes and glycemic control where recorded; antiresorptive therapy; selective serotonin reuptake inhibitor use; proton pump inhibitor use; history of head and neck irradiationPatient
OralHistory of periodontitis; bruxism (graded by a stated instrument); number of remaining teeth; maintenance attendancePatient
HistoryNumber of prior implants; prior implant failure (enters through the frailty update)Patient
SiteJaw; anterior or posterior region; bone quality category; grafted or native bone; immediate or healed siteImplant
ImplantLength; diameter; surface categoryImplant
Procedure (surgical-stage model only)Insertion torque; loading protocol; one- or two-stage; antibiotic prophylaxisImplant
ProviderSurgeon experience category; center (as a random effect, not a predictor)Cluster

Model development and comparison

Three models with identical predictors are fitted to the development data: (A) a proportional-hazards model treating implants as independent; (B) the same with robust standard errors clustered on patient, which corrects inference but not prediction; and (C) the gamma shared-frailty model of Equation 1. A gradient-boosted survival model with patient-grouped cross-validation is fitted as a machine-learning comparator, with all resampling performed at the patient level so that no patient contributes to both training and testing folds. Internal validation uses bootstrap resampling of patients, not implants. Shrinkage is applied according to the estimated optimism.

Sample size

For a time-to-event prediction model, the minimum development sample size can be set so that the expected uniform shrinkage factor S is at least 0.9. With p predictor parameters and an anticipated Cox-Snell R-squared of RCS2, the required number of independent observations is

n = p/((S - 1) ln(1 - R_CS^2 / S)) (6)

following published criteria [38, 39]. Rare outcomes imply small RCS2 and therefore large n. As a planning illustration only: with p = 25 parameters, S = 0.9, and an assumed RCS2 of 0.02, Equation 6 gives approximately 11,100 effective independent observations. If the design effect for a mean cluster size of four implants and an intraclass correlation of 0.2 is 1.6 by Equation 3, about 17,800 implants in about 4,450 patients would be needed. These inputs are assumptions; the RCS2 in particular must be estimated from pilot data or prior models before the calculation is relied upon. The exercise shows that most published implant prediction models were developed on samples too small for the number of predictors considered.

Validation and performance assessment

In each external dataset the models are applied without re-estimation. Discrimination is reported as Harrell's concordance and time-dependent area under the curve at one, five, and ten years. Calibration is reported as calibration-in-the-large, calibration slope, and smoothed calibration curves at the same horizons, for all implants and separately for first implants and for subsequent implants in patients with and without a prior failure. The Brier score and its scaled version are reported. Net benefit is plotted across a range of thresholds. Differences between models A and C in calibration slope and Brier score are estimated with confidence intervals by patient-level bootstrap. Heterogeneity of performance across centers is described, and the relatedness of development and validation samples is characterized [46].

Dynamic prediction

For each patient in the validation data with more than one implant placed at different times, the frailty expectation is updated by Equation 4 using only information available before each new implant. Predictions for that implant under the updated and non-updated models are compared. This analysis addresses the clinical scenario of retreatment after failure and of additional implants in a patient with an uneventful history.

7. Explicitly Labeled Theoretical Predictions

No model has been fitted. The following predictions follow from the structure in Section 5.

Prediction 1. The frailty variance will be clearly greater than zero. This is the least risky prediction, since clustering has been reported repeatedly [20, 25]; its failure would indicate that measured covariates fully explain the clustering, itself an important finding.

Prediction 2. Model A will be overconfident in external data, with a calibration slope below 1, because patients with many implants exert undue leverage on its coefficients and because its apparent precision encourages overfitting. Model C will have a slope nearer 1.

Prediction 3. Discrimination at baseline will differ little between models A and C. An evaluation that reported only the area under the curve would therefore miss the difference.

Prediction 4. For a patient with one early failure among the first two implants, the posterior expected frailty will exceed 1 by a margin that depends on θ. As an arithmetic illustration of Equation 4, if θ were 2 and the accumulated cumulative hazard 0.05, one observed failure would give an expected frailty of (0.5 + 1)/(0.5 + 0.05), approximately 2.7. The value of θ is unknown, and this number is not an estimate of any patient's risk.

Prediction 5. The machine-learning comparator will show higher apparent performance than model C under implant-level random splitting and similar or lower performance under patient-grouped validation, exposing leakage as a source of optimism in published work.

Table 2. Hypothesis components, expected results, and refuting results.
ComponentExpected under H4Refuting result
Between-patient heterogeneityFrailty variance interval excludes zeroInterval includes zero
External calibrationSlope of frailty model closer to 1; Brier score lower by 10 percent or moreSlope difference interval includes zero and Brier difference below 10 percent
Dynamic updatingBetter calibration for later implants using posterior frailtyNo improvement or deterioration
Phase structurePhase-specific frailties fit better than a single frailtySingle frailty adequate
LeakagePerformance falls under patient-grouped validationNo difference between splitting schemes

8. Discussion: Mechanisms and Competing Explanations

A frailty term is a statistical description of unexplained heterogeneity. It is silent about cause. Several mechanisms could generate it. Host biology is the explanation offered since the earliest reviews: differences in bone healing capacity, immune response, or systemic conditions not captured in the dental record [6]. Behavior is a second: smoking intensity, oral hygiene, and parafunction are measured crudely, and their unmeasured component would appear as frailty. The association of failure clusters with bruxism and antidepressant use [25] is compatible with both, since antidepressant use may mark depression-related behaviors, a direct pharmacologic effect on bone, or parafunction. A third mechanism is shared treatment: all implants in a patient are usually placed by the same surgeon, often in the same session, with the same protocol, and operator effects are documented [17, 18]. A contaminated procedure or an overheated osteotomy sequence affects every implant placed that day. A fourth is mechanical dependence: when one implant under a multi-unit prosthesis fails, load on the others changes. These mechanisms have different implications. Host frailty persists across treatment episodes; session-level effects do not. The dynamic-updating analysis, which examines implants placed at different times, favors detection of persistent susceptibility, and a three-level model with session nested in patient could separate the two if data allow.

The competing statistical position is that clustering should be handled by robust variance estimation alone. That corrects standard errors and leaves predictions unchanged; it treats clustering as a nuisance. The frailty approach treats it as signal. Which is preferable for prediction is the empirical question H4 poses, and there are reasons it might fail. If cluster sizes are small and most patients have one or two implants, the frailty is weakly identified and its posterior barely moves. If the gamma distribution is a poor description, for instance because a small subgroup of patients is highly susceptible and the rest are not, a discrete mixture would fit better and the gamma update would over- or under-react. The protocol includes a comparison with a two-class latent frailty for that reason.

A further competing view holds that flexible machine-learning methods will learn whatever structure exists without it being specified. In principle a model given patient history as input could learn the updating rule. In practice the evidence that machine learning outperforms regression for tabular clinical prediction is weak [33], the datasets available in implant dentistry are small by machine-learning standards, and radiograph-based models [28, 29] address a different question, the information content of images, that is complementary to and not a substitute for the structure proposed here. Image-derived features could enter the frailty model as predictors.

Censoring is a further source of competing explanations for any pattern the model finds. Patients who lose implants may leave the treating clinic, and patients who die or become too frail to attend are removed from observation without failing. If departure is related to impending failure, hazards are underestimated, and if it is related to patient characteristics that are also predictors, coefficient estimates are biased in ways that differ between centers. A frailty estimated from such data absorbs part of this distortion. The analysis therefore includes inverse-probability-of-censoring weights in a sensitivity analysis and reports how the frailty variance and the calibration comparison change, since a frailty that shrinks markedly under reweighting would suggest that part of the apparent heterogeneity in susceptibility is heterogeneity in follow-up.

The ethical dimension of prediction deserves a sentence. A model that labels patients as high risk may be used to deny treatment. Miscalibration that overstates risk in a subgroup would harm that subgroup. Calibration should therefore be examined within strata defined by age, sex, and, where recorded and appropriate, socioeconomic indicators, and the model should not be deployed where it has not been validated.

9. Implications for Implant Surgery and Restorative Dentistry

Until a validated model exists, the clinical implications are qualitative and follow from the evidence already published. A first implant failure should prompt reassessment of the patient and not merely of the site, with attention to smoking, parafunction, medication, periodontal status, and the possibility of a procedural cause common to the session. Risk communication should distinguish implant-level from patient-level figures: a 95 percent implant survival rate does not mean that 95 percent of patients keep all their implants, and the patient with eight planned implants faces a different prospect from the patient with one. Treatment planning for patients with a prior failure might reasonably favor conservative loading and closer review, although no trial shows that these measures reduce subsequent failure.

The arithmetic of multiple implants is worth making explicit in consent discussions. If each of eight implants had an independent 3 percent chance of failure, the chance that the patient would lose at least one would be about 22 percent; because failures cluster, the true figure for most patients is lower than this and for a susceptible minority much higher. Neither the implant-level percentage nor the independent-events calculation describes what a given patient should expect, which is the practical reason a patient-level model is needed.

For those building or evaluating risk calculators, the implications are concrete: analyze and validate at the patient level, report calibration, and distrust performance claims from random implant-level splits.

10. Technical and Clinical Limitations

The proposal depends on access to multi-center registries with reliable patient linkage and failure ascertainment, which are scarce. Retrospective data carry missing and inconsistently coded predictors; bruxism and bone quality are particularly unreliable. Loss to follow-up in implant cohorts is substantial and probably informative, since patients with problems may seek care elsewhere, which biases failure estimates in a direction that cannot be determined from the data alone. The gamma frailty is chosen for mathematical convenience. Proportional hazards may not hold. Failure is a crude outcome; an implant retained with advanced bone loss counts as a success. The model predicts failure risk under past practice patterns and may not transfer to new implant designs or protocols. Finally, a well-calibrated model with modest discrimination may still be of limited use for individual decisions, and that possibility should be reported plainly if it materializes.

11. Proposed Validation Pathway

The pathway has four stages with explicit gates. Stage 1 is a data-quality audit of candidate registries: completeness of linkage, follow-up, and predictor recording; registries failing predefined thresholds are excluded. Stage 2 is estimation of the frailty variance and the Cox-Snell R-squared in one registry to finalize the sample-size calculation; if the frailty variance interval includes zero, the program stops and that result is reported. Stage 3 is model development and internal validation as described. Stage 4 is external validation in at least two independent datasets, with the comparison of models A and C as the primary analysis. Only after Stage 4 would an impact study be considered, in which the model's predictions are provided to clinicians and the effect on decisions and outcomes is assessed, ideally in a cluster-randomized design. Presentation of the model as a risk calculator before external validation would be premature.

12. Future Research Directions

Three extensions are natural. Joint modeling of failure with longitudinal marginal bone level would allow biological complications to inform failure risk before the implant is lost. Standardized recording of the least reliable predictors, through validated bruxism instruments and quantitative bone assessment, would reduce the unexplained heterogeneity that the frailty currently absorbs. And linkage of dental registries with medical and pharmacy records would allow the medication associations reported in single cohorts [9, 10] to be examined with proper control for indication. The prospect of a learning registry, in which each new outcome updates both the population model and the individual patient's frailty, is a logical endpoint that depends on data infrastructure more than on statistical innovation.

13. Evidence-Calibrated Conclusion

That implant failures cluster within patients is supported by multiple cohort analyses over three decades. That specific exposures, smoking most consistently, raise failure risk is supported by meta-analyses of observational studies, with residual confounding likely. That existing prediction models are methodologically limited and seldom externally validated is the conclusion of a recent systematic appraisal. That a shared-frailty model with dynamic updating would calibrate better than implant-level models is a hypothesis; it has theoretical support and has not been tested in implant data to our knowledge. This manuscript sets out the model, the updating rule, the sample-size reasoning, and the results that would refute the hypothesis. It reports no fitted model and makes no claim about predictive performance.

Cite this paper

Jain S, Gupta A. Predicting Dental Implant Failure When Failures Cluster in Patients: A Critical Appraisal of Existing Models and a TRIPOD+AI Protocol for a Shared-Frailty Model With Dynamic Updating. Working paper. Center for Implant Dentistry; 2026. Available from: https://bayareaimplantdentistry.com/clinician-research-and-publications/clustering-aware-prediction-of-implant-failure

References

  1. Howe MS, Keys W, Richards D. Long-term (10-year) dental implant survival: A systematic review and sensitivity meta-analysis. J Dent. 2019;84:9-21. doi:10.1016/j.jdent.2019.03.008 (opens in a new tab) PMID: 30904559 (opens in a new tab).
  2. Moraschini V, Poubel LA, Ferreira VF, Barboza Edos S. Evaluation of survival and success rates of dental implants reported in longitudinal studies with a follow-up period of at least 10 years: a systematic review. Int J Oral Maxillofac Surg. 2015;44(3):377-88. doi:10.1016/j.ijom.2014.10.023 (opens in a new tab) PMID: 25467739 (opens in a new tab).
  3. Derks J, Håkansson J, Wennström JL, Tomasi C, Larsson M, Berglundh T. Effectiveness of implant therapy analyzed in a Swedish population: early and late implant loss. J Dent Res. 2015;94(3 Suppl):44S-51S. doi:10.1177/0022034514563077 (opens in a new tab) PMID: 25503901 (opens in a new tab).
  4. Chrcanovic BR, Albrektsson T, Wennerberg A. Reasons for failures of oral implants. J Oral Rehabil. 2014;41(6):443-76. doi:10.1111/joor.12157 (opens in a new tab) PMID: 24612346 (opens in a new tab).
  5. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. (I). Success criteria and epidemiology. Eur J Oral Sci. 1998;106(1):527-51. doi:10.1046/j.0909-8836..t01-2-.x (opens in a new tab) PMID: 9527353 (opens in a new tab).
  6. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. (II). Etiopathogenesis. Eur J Oral Sci. 1998;106(3):721-64. doi:10.1046/j.0909-8836..t01-6-.x (opens in a new tab) PMID: 9672097 (opens in a new tab).
  7. Chrcanovic BR, Albrektsson T, Wennerberg A. Smoking and dental implants: A systematic review and meta-analysis. J Dent. 2015;43(5):487-98. doi:10.1016/j.jdent.2015.03.003 (opens in a new tab) PMID: 25778741 (opens in a new tab).
  8. Chrcanovic BR, Albrektsson T, Wennerberg A. Diabetes and oral implant failure: a systematic review. J Dent Res. 2014;93(9):859-67. doi:10.1177/0022034514538820 (opens in a new tab) PMID: 24928096 (opens in a new tab).
  9. Wu X, Al-Abedalla K, Rastikerdar E, Abi Nader S, Daniel NG, Nicolau B, et al. Selective serotonin reuptake inhibitors and the risk of osseointegrated implant failure: a cohort study. J Dent Res. 2014;93(11):1054-61. doi:10.1177/0022034514549378 (opens in a new tab) PMID: 25186831 (opens in a new tab).
  10. Wu X, Al-Abedalla K, Abi-Nader S, Daniel NG, Nicolau B, Tamimi F. Proton Pump Inhibitors and the Risk of Osseointegrated Dental Implant Failure: A Cohort Study. Clin Implant Dent Relat Res. 2017;19(2):222-232. doi:10.1111/cid.12455 (opens in a new tab) PMID: 27766743 (opens in a new tab).
  11. Chrcanovic BR, Kisch J, Albrektsson T, Wennerberg A. Intake of Proton Pump Inhibitors Is Associated with an Increased Risk of Dental Implant Failure. Int J Oral Maxillofac Implants. 2017;32(5):1097–1102. doi:10.11607/jomi.5662 (opens in a new tab) PMID: 28632255 (opens in a new tab).
  12. Chrcanovic BR, Kisch J, Albrektsson T, Wennerberg A. Factors Influencing Early Dental Implant Failures. J Dent Res. 2016;95(9):995-1002. doi:10.1177/0022034516646098 (opens in a new tab) PMID: 27146701 (opens in a new tab).
  13. Chrcanovic BR, Kisch J, Albrektsson T, Wennerberg A. Bruxism and dental implant failures: a multilevel mixed effects parametric survival analysis approach. J Oral Rehabil. 2016;43(11):813-823. doi:10.1111/joor.12431 (opens in a new tab) PMID: 27611304 (opens in a new tab).
  14. Jemt T. A retro-prospective effectiveness study on 3448 implant operations at one referral clinic: A multifactorial analysis. Part I: Clinical factors associated to early implant failures. Clin Implant Dent Relat Res. 2017;19(6):980-988. doi:10.1111/cid.12539 (opens in a new tab) PMID: 28884953 (opens in a new tab).
  15. Moy PK, Medina D, Shetty V, Aghaloo TL. Dental implant failure rates and associated risk factors. Int J Oral Maxillofac Implants. 2005;20(4):569-77. PMID: 16161741 (opens in a new tab).
  16. French D, Larjava H, Ofec R. Retrospective cohort study of 4591 Straumann implants in private practice setting, with up to 10-year follow-up. Part 1: multivariate survival analysis. Clin Oral Implants Res. 2015;26(11):1345-54. doi:10.1111/clr.12463 (opens in a new tab) PMID: 25134415 (opens in a new tab).
  17. Chrcanovic BR, Kisch J, Albrektsson T, Wennerberg A. Impact of Different Surgeons on Dental Implant Failure. Int J Prosthodont. 2017;30(5):445–454. doi:10.11607/ijp.5151 (opens in a new tab) PMID: 28806425 (opens in a new tab).
  18. Sendyk DI, Chrcanovic BR, Albrektsson T, Wennerberg A, Zindel Deboni MC. Does Surgical Experience Influence Implant Survival Rate? A Systematic Review and Meta-Analysis. Int J Prosthodont. 2017;30(30):341-347. doi:10.11607/ijp.5211 (opens in a new tab) PMID: 28697203 (opens in a new tab).
  19. Jemt T, Olsson M, Franke Stenport V. Incidence of First Implant Failure: A Retroprospective Study of 27 Years of Implant Operations at One Specialist Clinic. Clin Implant Dent Relat Res. 2015;17 Suppl 2:e501-10. doi:10.1111/cid.12277 (opens in a new tab) PMID: 25536273 (opens in a new tab).
  20. Weyant RJ, Burt BA. An assessment of survival rates and within-patient clustering of failures for endosseous oral implants. J Dent Res. 1993;72(1):2-8. doi:10.1177/00220345930720010201 (opens in a new tab) PMID: 8380286 (opens in a new tab).
  21. Herrmann I, Lekholm U, Holm S, Karlsson S. Impact of implant interdependency when evaluating success rates: a statistical analysis of multicenter results. Int J Prosthodont. 1999;12(2):160-6. PMID: 10371919 (opens in a new tab).
  22. Chuang SK, Tian L, Wei LJ, Dodson TB. Kaplan-Meier analysis of dental implant survival: a strategy for estimating survival with clustered observations. J Dent Res. 2001;80(11):2016-20. doi:10.1177/00220345010800111301 (opens in a new tab) PMID: 11759013 (opens in a new tab).
  23. Chuang SK, Cai T, Douglass CW, Wei LJ, Dodson TB. Frailty approach for the analysis of clustered failure time observations in dental research. J Dent Res. 2005;84(1):54-8. doi:10.1177/154405910508400109 (opens in a new tab) PMID: 15615876 (opens in a new tab).
  24. Herrmann I, Lekholm U, Holm S, Kultje C. Evaluation of patient and implant characteristics as potential prognostic factors for oral implant failures. Int J Oral Maxillofac Implants. 2005;20(2):220-30. PMID: 15839115 (opens in a new tab).
  25. Chrcanovic BR, Kisch J, Albrektsson T, Wennerberg A. Analysis of risk factors for cluster behavior of dental implant failures. Clin Implant Dent Relat Res. 2017;19(4):632-642. doi:10.1111/cid.12485 (opens in a new tab) PMID: 28332286 (opens in a new tab).
  26. Zhu Y, Du M, Li P, Lu H, Li A, Xu S. Prediction models for the complication incidence and survival rate of dental implants-a systematic review and critical appraisal. Int J Implant Dent. 2025;11(1):5. doi:10.1186/s40729-025-00590-1 (opens in a new tab) PMID: 39847174 (opens in a new tab).
  27. Wolff RF, Moons KGM, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies. Ann Intern Med. 2019;170(1):51-58. doi:10.7326/M18-1376 (opens in a new tab) PMID: 30596875 (opens in a new tab).
  28. Huang N, Liu P, Yan Y, Xu L, Huang Y, Fu G, et al. Predicting the risk of dental implant loss using deep learning. J Clin Periodontol. 2022;49(9):872-883. doi:10.1111/jcpe.13689 (opens in a new tab) PMID: 35734921 (opens in a new tab).
  29. Oh S, Kim YJ, Kim J, Jung JH, Lim HJ, Kim BC, et al. Deep learning-based prediction of osseointegration for dental implant using plain radiography. BMC Oral Health. 2023;23(1):208. doi:10.1186/s12903-023-02921-3 (opens in a new tab) PMID: 37031221 (opens in a new tab).
  30. Papantonopoulos G, Gogos C, Housos E, Bountis T, Loos BG. Prediction of individual implant bone levels and the existence of implant "phenotypes". Clin Oral Implants Res. 2017;28(7):823-832. doi:10.1111/clr.12887 (opens in a new tab) PMID: 27252014 (opens in a new tab).
  31. Revilla-León M, Gómez-Polo M, Vyas S, Barmak BA, Galluci GO, Att W, et al. Artificial intelligence applications in implant dentistry: A systematic review. J Prosthet Dent. 2023;129(2):293-300. doi:10.1016/j.prosdent.2021.05.008 (opens in a new tab) PMID: 34144789 (opens in a new tab).
  32. Schwendicke F, Samek W, Krois J. Artificial Intelligence in Dentistry: Chances and Challenges. J Dent Res. 2020;99(7):769-774. doi:10.1177/0022034520915714 (opens in a new tab) PMID: 32315260 (opens in a new tab).
  33. Christodoulou E, Ma J, Collins GS, Steyerberg EW, Verbakel JY, Van Calster B. A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models. J Clin Epidemiol. 2019;110:12-22. doi:10.1016/j.jclinepi.2019.02.004 (opens in a new tab) PMID: 30763612 (opens in a new tab).
  34. Albrektsson T, Zarb G, Worthington P, Eriksson AR. The long-term efficacy of currently used dental implants: a review and proposed criteria of success. Int J Oral Maxillofac Implants. 1986;1(1):11-25. PMID: 3527955 (opens in a new tab).
  35. Misch CE, Perel ML, Wang HL, Sammartino G, Galindo-Moreno P, Trisi P, et al. Implant success, survival, and failure: the International Congress of Oral Implantologists (ICOI) Pisa Consensus Conference. Implant Dent. 2008;17(1):5-15. doi:10.1097/ID.0b013e3181676059 (opens in a new tab) PMID: 18332753 (opens in a new tab).
  36. Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378. doi:10.1136/bmj-2023-078378 (opens in a new tab) PMID: 38626948 (opens in a new tab).
  37. Moons KGM, Damen JAA, Kaul T, Hooft L, Andaur Navarro C, Dhiman P, et al. PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods. BMJ. 2025;388:e082505. doi:10.1136/bmj-2024-082505 (opens in a new tab) PMID: 40127903 (opens in a new tab).
  38. Riley RD, Snell KI, Ensor J, Burke DL, Harrell FE Jr, Moons KG, et al. Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes. Stat Med. 2019;38(7):1276-1296. doi:10.1002/sim.7992 (opens in a new tab) PMID: 30357870 (opens in a new tab).
  39. Riley RD, Ensor J, Snell KIE, Harrell FE Jr, Martin GP, Reitsma JB, et al. Calculating the sample size required for developing a clinical prediction model. BMJ. 2020;368:m441. doi:10.1136/bmj.m441 (opens in a new tab) PMID: 32188600 (opens in a new tab).
  40. Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW, Topic Group ‘Evaluating diagnostic tests and prediction models’ of the STRATOS initiative. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019;17(1):230. doi:10.1186/s12916-019-1466-7 (opens in a new tab) PMID: 31842878 (opens in a new tab).
  41. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128-38. doi:10.1097/EDE.0b013e3181c30fb2 (opens in a new tab) PMID: 20010215 (opens in a new tab).
  42. Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565-74. doi:10.1177/0272989X06295361 (opens in a new tab) PMID: 17099194 (opens in a new tab).
  43. Wynants L, Bouwmeester W, Moons KG, Moerbeek M, Timmerman D, Van Huffel S, et al. A simulation study of sample size demonstrated the importance of the number of events per variable to develop prediction models in clustered data. J Clin Epidemiol. 2015;68(12):1406-14. doi:10.1016/j.jclinepi.2015.02.002 (opens in a new tab) PMID: 25817942 (opens in a new tab).
  44. Bouwmeester W, Twisk JW, Kappen TH, van Klei WA, Moons KG, Vergouwe Y. Prediction models for clustered data: comparison of a random intercept and standard regression model. BMC Med Res Methodol. 2013;13:19. doi:10.1186/1471-2288-13-19 (opens in a new tab) PMID: 23414436 (opens in a new tab).
  45. Austin PC. A Tutorial on Multilevel Survival Analysis: Methods, Models and Applications. Int Stat Rev. 2017;85(2):185-203. doi:10.1111/insr.12214 (opens in a new tab) PMID: 29307954 (opens in a new tab).
  46. Debray TP, Vergouwe Y, Koffijberg H, Nieboer D, Steyerberg EW, Moons KG. A new framework to enhance the interpretation of external validation studies of clinical prediction models. J Clin Epidemiol. 2015;68(3):279-89. doi:10.1016/j.jclinepi.2014.06.018 (opens in a new tab) PMID: 25179855 (opens in a new tab).
  47. Reference verification note. 46 of 46 references are PubMed-indexed; their bibliographic records (authors, title, journal, year, volume, pages, DOI, PMID) were retrieved programmatically from the PubMed database on November 17, 2026. Database retrieval confirms that each record exists as cited; it does not replace full-text reading by the responsible authors of every statement attributed to a source.